Endovascular Stem Cell Therapy Post Stroke Rescues Neurons from Endoplasmic Reticulum Stress-Induced Apoptosis by Modulating Brain-Derived Neurotrophic Factor/Tropomyosin Receptor Kinase B Signaling
- 23 September 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 12 (19) , 3745-3759
Abstract
Ischemic stroke is devastating, with serious long-term disabilities affecting millions of people worldwide. Growing evidence has shown that mesenchymal stem cells (MSCs) administration after stroke provides neuroprotection and enhances the quality of life in stroke patients. Previous studies from our lab have shown that 1 × 105 MSCs administered intra-arterially (IA) at 6 h post stroke provide neuroprotection through the modulation of inflammasome and calcineurin signaling. Ischemic stroke induces endoplasmic reticulum (ER) stress, which exacerbates the pathology. The current study intends to understand the involvement of brain-derived neurotrophic factor/tropomyosin receptor kinase B (BDNF/TrkB) signaling in preventing apoptosis induced by ER stress post stroke following IA MSCs administration. Ischemic stroke was induced in ovariectomized female Sprague Dawley rats. The MSCs were administered IA, and animals were sacrificed at 24 h post stroke. Infarct area, neurological deficit score, motor coordination, and biochemical parameters were evaluated. The expression of various genes and proteins was assessed. An inhibition study was also carried out to confirm the involvement of BDNF/TrkB signaling in ER stress-induced apoptosis. IA-administered MSCs improved functional outcomes, reduced infarct area, increased neuronal survival, and normalized biochemical parameters. mRNA and protein expression of ER stress markers were reduced, while those of BDNF and TrkB were increased. Reduction in ER stress-mediated apoptosis was also observed. The present study shows that IA MSCs administration post stroke provides neuroprotection and can modulate ER stress-mediated apoptosis via the BDNF/TrkB signaling pathway.Keywords
Funding Information
- Indian Council of Medical Research (5/3/8/16/ITR-F/2019-ITR)
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
- National Institute of Pharmaceutical Education and Research, Ahmedabad
This publication has 62 references indexed in Scilit:
- Cell Size and Velocity of Injection are Major Determinants of the Safety of Intracarotid Stem Cell TransplantationJournal of Cerebral Blood Flow & Metabolism, 2013
- Brain-derived neurotrophic factor increases expression of MnSOD in human circulating angiogenic cellsMicrovascular Research, 2012
- Glibenclamide Administration Attenuates Infarct Volume, Hemispheric Swelling, and Functional Impairments following Permanent Focal Cerebral Ischemia in RatsStroke Research and Treatment, 2012
- Identification of Ischemic Regions in a Rat Model of StrokePLOS ONE, 2009
- Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient IschemiaStroke, 2008
- Involvement of endoplasmic reticulum stress after middle cerebral artery occlusion in miceNeuroscience, 2007
- Brain‐derived neurotrophic factor suppresses tunicamycin‐induced upregulation of CHOP in neuronsJournal of Neuroscience Research, 2007
- Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling methodNature Protocols, 2006
- Stilbazulenyl Nitrone, a Second-Generation Azulenyl Nitrone Antioxidant, Confers Enduring Neuroprotection in Experimental Focal Cerebral Ischemia in the Rat: Neurobehavior, Histopathology, and PharmacokineticsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989